Friday, February 25, 2022 11:46:48 AM
CaptainObvious,
This is why I spent a good deal of time doing due diligence on Linda early on. I wanted to know her underlying motivations, decisive decision making ability, planning, experience, understanding of the science, foresight as to it’s broad applicability, tenacity and ability to persevere. In biotech it’s about the science, strategy, leadership execution and time. NWBO has derisked every area now to the point that all that’s left is time and that has been reduced dramatically more than the current price suggests but awareness lags because of the strategy. So who should be benefitting the most from understanding this, current investors or the uninformed broader market and who do you think are more friendly towards Linda’s plans, current investors or the general market?; ). Tag, you’re it ; ). Best wishes.
This is why I spent a good deal of time doing due diligence on Linda early on. I wanted to know her underlying motivations, decisive decision making ability, planning, experience, understanding of the science, foresight as to it’s broad applicability, tenacity and ability to persevere. In biotech it’s about the science, strategy, leadership execution and time. NWBO has derisked every area now to the point that all that’s left is time and that has been reduced dramatically more than the current price suggests but awareness lags because of the strategy. So who should be benefitting the most from understanding this, current investors or the uninformed broader market and who do you think are more friendly towards Linda’s plans, current investors or the general market?; ). Tag, you’re it ; ). Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
